Ross Houston appointed chief scientific officer at Benchmark Genetics.
Benchmark Genetics has appointed Dr. Ross Houston as its new chief scientific officer (CSO), the company announced.
In his new role, Houston will lead global research and development, oversee breeding programmes and product design, and drive strategic initiatives following the company’s transition to an independent business under the Novo Holdings portfolio.
Houston joined Benchmark in 2022 from the Roslin Institute, where he held the position of Chair of Aquaculture Genetics. He is recognised for his work in applying genomic technologies to aquaculture breeding programmes, with nearly 150 peer-reviewed publications and several patents.
At Benchmark, he has led the development of the company’s Reproductive Technologies team and established a molecular genetics laboratory offering advanced genotyping services to aquaculture producers.
As CSO, Houston will report to CEO Dr. Geir Olav Melingen and join the company’s board.
“I’m honored to take up this new leadership position at a very exciting time in Benchmark Genetics’ journey. The power and value of innovation in genetics technologies to sustainable seafood production is clear, and I will focus on unlocking this potential by translating the latest science into commercial practice,” Houston said.